BACTERICIDAL ACTIVITY OF LEUKOCYTES IN PULMONARY TUBERCULOSIS PATIENTS
https://doi.org/10.21292/2075-1230-2017-95-10-37-44
Abstract
Bactericidal activity of leukocytes was investigated in 63 patients with new infiltrate pulmonary tuberculosis and 28 patients with fibrous cavernous pulmonary tuberculosis. The diverse oxygen-dependent bactericidal activity of phagocytes is typical of the patients suffering from both clinical forms of tuberculosis: reduction of nitrosative stress rates, which is more frequent in those suffering from fibrous cavernous tuberculosis, and increase of oxidative stress rates, which is more intensive in case of fibrous cavernous tuberculosis. The associated functions were detected among immune-competent cells, involved in the bactericidal function: in case of fibrous cavernous tuberculosis – between oxidative stress rates, and in case of infiltrate pulmonary tuberculosis – between nitrosative stress rates; the synergistic effect of respiratory burst was observed. In case of chronic pulmonary tuberculosis, both types of cells were equally responsible for bactericidal functions, while neutrophils were dominating in new infiltrate pulmonary tuberculosis, without prior treatment, being the cells of the first line of defense. The obtained results allowed concluding that in case of new pulmonary tuberculosis without prior treatment, nitrosative stress played the important role in the killing of tuberculous mycobacteria, while in case of chronic tuberculosis – it was oxidative stress.
About the Authors
M. E. Dyakova
Saint-Petersburg State Research Institute of Phthisiopulmonology
Russian Federation
Russian Federation
Candidate of Biological Sciences, Senior Researcher,
32, Polytechnicheskaya St., St. Petersburg, 194064
D. S. Esmedlyaeva
Saint-Petersburg State Research Institute of Phthisiopulmonology
Russian Federation
Russian Federation
Candidate of Biological Sciences, Senior Researcher,
32, Polytechnicheskaya St., St. Petersburg, 194064
T. L. Perova
Saint-Petersburg State Research Institute of Phthisiopulmonology
Russian Federation
Russian Federation
Researcher,
32, Polytechnicheskaya St., St. Petersburg, 194064
N. N. Petrischev
Pavlov First Saint Petersburg State Medical University
Russian Federation
Russian Federation
Doctor of Medical Sciences, Professor, Head of Laser Medicine Center,
6-8, Lva Tolstogo St., St. Petersburg, 197022
P. K. Yablonsky
Saint-Petersburg State Research Institute of Phthisiopulmonology;
St. Petersburg University
Russian Federation
Russian Federation
Petr K. Yablonsky Doctor of Medical Sciences, Professor, Director,
32, Polytechnicheskaya St., St. Petersburg, 194064
References
1. Аbdullaev R.Yu., Kaminskaya G.O., Komissarova O.G. Changes in hemostasis system – components of system inflammatory response syndrome in pulmonary tuberculosis. Vrach, 2012, no. 2, pp. 24-28. (In Russ.)
2. Dyakova M.E., Titarenko O.T., Esmedlyaeva D.S., Elkin А.V., Tabanakova I.А., Аlekseeva N.P. Functional activity of phagocytes in fibrous cavernous tuberculosis. Voprosy Иiologicheskoн, Meditsinskoy i Farmatsevticheskoy Khimii, 2008, no. 2, pp. 15-19. (In Russ.)
3. Dyakova M.E. Specific features of purine metabolism in pulmonary tuberculosis patients. Patologicheskaya Fiziologiya i Eksperimentalnaya Terapiya, 2016, vol. 61, no. 3, pp. 36-42. (In Russ.)
4. Kaminskaya G.O., Аbdullaev R.Yu., Serebryanaya B.А. Quality evaluation of metabolic changes associated with fast progressing pulmonary tuberculosis. Probl. Tub., 2006, no. 8, pp. 53-57. (In Russ.)
5. Karimov I.Z., Shavlovskiy M.M., Nazarov P.G. Changes in level of C-reactive protein and other proteins of acute phase in the blood of viral hepatitis patients, Tsitokiny i Vospaleniye, 2004, vol. 3, no. 4, pp. 42-46. (In Russ.)
6. Reutov V.P. Cycle of nitrogen oxides in the mammals. Uspekhi Biologicheskoy Khimii, 1995, vol. 35, pp. 189-228. (In Russ.)
7. Sviridov E.А., Telegina T.А. Neopterin and its reduced forms: biological role and involvement into the cellular immunity. Uspekhi Biologicheskoy Khimii, 2005, vol. 45, pp. 355-390. (In Russ.)
8. Strelis А.K., Novitskiy V.V., Urazova O.I., Zemlyanaya N.А., Voronkova O.V., Filinyuk O.V., Pirogova N.P., Serebryakova V.А., Buynova L.N., Esimova I.E. Production of nitrogen oxide by mononuclear cells of those with drug susceptible and drug resistant pulmonary tuberculosis. Bulleten' Sibirskoy Meditsiny, 2006, vol. 5, no. 4, pp. 57-61. (In Russ.)
9. Totolyan А.А., Baldueva I.А., Bubnova L.N., Zakrevskaya А.V., Zueva E.E., Kalinina N.M., Lisitsina Z.N. Standardization of immune-phenotyping methods of human blood and bone marrow cells. Klin. Laboratornaya Diagnostika, 2001, no. 8, pp. 38-45. (In Russ.)
10. Bryan N.S., Bian K., Murad F. Discovery of the nitric oxide signaling pathway and targets for drug development. Front. Biosci., 2009, vol. 14, no. 1, pp. 1-18. doi: 10.2741/3228.
11. Chakravortty D., Hensel M. Inducible nitric oxide synthase and control of intracellular bacterial pathogens. Microbes Infect., 2003, vol. 4, pp. 621-627. doi: 10.1016/S1286-4579(03)00096-0.
12. Chan E.D., Chan J., Schluger N.W. What is the role of nitric oxide in murine and human defense against tuberculosis? Am. J. Respir. Cell Mol. Biol., 2001, vol. 25, pp. 606-612.
13. Hochepied T., Berger F., Baumann H., Libert C. Alpha-1-acid glycoprotein: an acute phase protein with inflammantory and immunomodulating properties. Cytokine Growth Factor Rev., 2003, vol. 14, no. 1, pp. 25-34.
14. Janciauskiene S.M., Nita J.M., Stevens T. Alpha1-antitrypsin, old dog, new tricks. α1-antitrypsin exerts in vitro antiinflamatory activity in human monocytes by elevating cAMP. J. Biol., Chem., 2007, vol. 282, pp. 8573-8582. doi: 10.1074/jbc. M607976200.
15. Kälvegren H., Fridfeldt J., Bengtsson T. The role of plasma adenosine deaminase in chemoattractant-stimulated oxygen radical production in neutrophils. Eur. J. Cell Biol., 2010, vol. 89, no. 6, pp. 462-467. doi:10.1016/j.ejcb.2009.12.004.
16. Kuo H.P., Wang C.H., Huang K.S., Lin H.C., Yu C.T., Liu C.Y., Lu L.C. Nitric oxide modulates interleukin-1β and tumor necrosis factor-α synthesis by alveolar macrophages in pulmonary tuberculosis. Am. J. Respir. Crit. Care Med., vol. 161, pp. 192-199.
17. Maiuolo J., Oppedisano F., Gratteri S., Muscoli C., Mollace V. Regulation of uric acid metabolism and excretion. Int. J. Cardiology, 2016, vol. 213, pp. 8-14. doi: 10.1016/j.ijcard.2015.08.109.
18. Mir M.M., Khan A. R., Dar N.A., Salahuddin M. Polymorphonuclear leukocyte mediated oxidative inactivation of alpha-1-proteinase inhibitor: modulation by nitric oxide. Indian J. Clin. Biochem., 2005, vol. 20, no. 1, pp. 184-192. doi:10.1007/BF02893068.
19. Miranda M.S., Wek Rodrigues K., Cordero E.M., Rojas-Espinosa O. Expression of cyclooxygenase-2, alpha 1-acid-glycoprotein and inducible nitric oxide synthase in the developing lesions of murine leprosy. Int. J. Exp. Path., 2006, vol. 87, pp. 485-494. doi: 10.1111/i.1365-2613.2006.00504.
20. Miyamoto Y., Akaike T., Maeda H.S-nitrosylated human alpha(1)-protease inhibitor. Biochim. Biophys. Acta., 2000, vol. 1477, pp. 90-97.
21. Nagy G., Koncz A., Telarico T., Fernandez D., Ersek B., Buzas E., Perl A. Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Arthritis Research &Therapy, 2010, vol. 12, pp. 210. doi: 10.1186/ar3045.
22. Shiloh M.U., Nathan С.F. Reactive nitrogen intermediates and the pathogenesis of Salmonella and Mycobacteria. Curr. Opin. Microbiol., 2000, vol. 3, pp. 35-42.
23. Titarenko O.T., Dyakova M.E., Esmedlyaeva D.S., Pavlova M.V., Yelkin A.V., Alekseeva N.P., Bondarenko B.B. Peculiarities of functional activity of circulating phagocytes in patients with different forms of drug-resistant pulmonary tuberculosis. Biochem. (Mosc.) suppl. Series B: Biomedical Chemistry, 2011, vol. 5, no. 3, pp. 301-306.
24. Yang C.S., Yuk J.M., Jo E.K. The role of nitric oxide in mycobacterial infections. Immune Netw., 2009, vol. 9, no. 2, pp. 46-52. doi: 10.4110/in.2009.9.2.46.
Review
For citations:
Dyakova M.E., Esmedlyaeva D.S., Perova T.L., Petrischev N.N., Yablonsky P.K. BACTERICIDAL ACTIVITY OF LEUKOCYTES IN PULMONARY TUBERCULOSIS PATIENTS. Tuberculosis and Lung Diseases. 2017;95(10):37-44. (In Russ.) https://doi.org/10.21292/2075-1230-2017-95-10-37-44
Views:
1787
Email this article 